Get the Stockscreener App
231.69
0.47%
-1.10
After Hours:
231.69
Overview
News
Price History
Option Chain
Financials
Why RMD Down?
Discussions
Forecast
Stock Split
Dividend History
Resmed Inc stock is traded at $231.69, with a volume of 499.15K.
It is down -0.47% in the last 24 hours and down -6.50% over the past month.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
See More
Previous Close:
$232.79
Open:
$232.31
24h Volume:
499.15K
Relative Volume:
0.62
Market Cap:
$34.04B
Revenue:
$4.93B
Net Income/Loss:
$1.25B
P/E Ratio:
27.35
EPS:
8.47
Net Cash Flow:
$1.38B
1W Performance:
-0.55%
1M Performance:
-6.50%
6M Performance:
+3.29%
1Y Performance:
+28.51%
1-Day Range:
$230.34
$233.38
1-Week Range:
$228.87
$240.00
52-Week Range:
$170.56
$263.05
Resmed Inc Stock (RMD) Company Profile
Name
Resmed Inc
Sector
Industry
Phone
(858) 746-2400
Address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Compare RMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
231.69 | 34.04B | 4.93B | 1.25B | 1.38B | 8.47 |
|
ISRG
Intuitive Surgical Inc
|
591.79 | 211.07B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.43 | 65.30B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.31 | 44.67B | 9.76B | 1.16B | 665.00M | 2.34 |
|
COO
The Cooper Companies, Inc.
|
88.48 | 17.62B | 3.90B | 392.30M | 288.10M | 1.95 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-16-25 | Initiated | Goldman | Buy |
| Jan-10-25 | Initiated | Piper Sandler | Neutral |
| Dec-13-24 | Initiated | Stifel | Hold |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Sep-18-24 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Sep-04-24 | Downgrade | Needham | Buy → Hold |
| Jun-25-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Jun-24-24 | Downgrade | Citigroup | Buy → Neutral |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Oct-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-12-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-09-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-29-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-06-23 | Upgrade | Needham | Hold → Buy |
| Sep-05-23 | Downgrade | UBS | Buy → Neutral |
| Aug-01-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-23-23 | Initiated | UBS | Buy |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Jan-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-20-22 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Sep-08-22 | Upgrade | Citigroup | Neutral → Buy |
| Aug-15-22 | Downgrade | CLSA | Buy → Outperform |
| Aug-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-12-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jun-06-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Jan-31-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-31-22 | Upgrade | Goldman | Neutral → Buy |
| Jan-28-22 | Upgrade | RBC Capital Mkts | Underperform → Sector Perform |
| Jan-24-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-24-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Jan-13-22 | Upgrade | CLSA | Outperform → Buy |
| Jan-13-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-21-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-06-21 | Upgrade | Macquarie | Neutral → Outperform |
| Oct-22-21 | Upgrade | CLSA | Underperform → Outperform |
| Aug-02-21 | Downgrade | CLSA | Outperform → Sell |
| Aug-02-21 | Downgrade | Needham | Buy → Hold |
| Jul-28-21 | Upgrade | Jefferies | Underperform → Hold |
| Jul-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-14-21 | Initiated | RBC Capital Mkts | Underperform |
| Jun-28-21 | Downgrade | Citigroup | Buy → Neutral |
| Jun-22-21 | Upgrade | Macquarie | Neutral → Outperform |
| Jun-22-21 | Initiated | Robert W. Baird | Neutral |
| Jun-21-21 | Reiterated | Needham | Buy |
| Jun-16-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-09-21 | Upgrade | CLSA | Sell → Outperform |
| May-21-21 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-21 | Upgrade | Citigroup | Neutral → Buy |
| Apr-30-21 | Downgrade | Citigroup | Buy → Neutral |
| Mar-16-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-20 | Upgrade | UBS | Neutral → Buy |
| Oct-30-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Oct-27-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-07-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-17-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-01-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-01-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Feb-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-03-20 | Initiated | CLSA | Underperform |
| Jan-31-20 | Downgrade | UBS | Buy → Neutral |
| Jan-10-20 | Initiated | Oppenheimer | Perform |
| Nov-22-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-29-19 | Upgrade | UBS | Neutral → Buy |
| Jul-16-19 | Downgrade | UBS | Buy → Neutral |
| May-06-19 | Upgrade | UBS | Neutral → Buy |
| Apr-18-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-25-19 | Downgrade | Goldman | Buy → Neutral |
| Jan-25-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-26-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-02-18 | Initiated | Goldman | Buy |
View All
Resmed Inc Stock (RMD) Latest News
6,300 Shares in ResMed Inc. (NYSE:RMD) Acquired by Hussman Strategic Advisors Inc. - MarketBeat
Ieq Capital LLC Grows Stock Position in ResMed Inc. (NYSE:RMD) - MarketBeat
Alberta Investment Management Corp Acquires Shares of 10,400 ResMed Inc. (NYSE:RMD) - MarketBeat
Pittenger & Anderson Inc. Has $14.30 Million Position in ResMed Inc. (NYSE:RMD) - MarketBeat
3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD) - MSN
ResMed (NYSE:RMD) Shares Gap UpHere's Why - MarketBeat
Cumberland Partners Ltd Acquires 11,000 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Convergence Investment Partners LLC Invests $1.03 Million in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Shares Purchased by Asset Management One Co. Ltd. - MarketBeat
Chevy Chase Trust Holdings LLC Sells 1,752 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
AustralianSuper Pty Ltd Increases Position in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Shares Sold by Congress Asset Management Co. - MarketBeat
Assistive Technology Market Is Booming Worldwide 2025-2032: Permobil AB, Sunrise Medical LLC., Tobii AB, - EIN News
ResMed (NYSE:RMD) Stock Unloaded Rep. Robert Bresnahan, Jr. - MarketBeat
Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 26%? - Yahoo Finance
Nations Financial Group Inc. IA ADV Acquires New Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
Entropy Technologies LP Sells 6,581 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Empowered Funds LLC Has $2.77 Million Stock Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
Rhumbline Advisers Sells 13,536 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Holdings Lifted by Van ECK Associates Corp - MarketBeat
Banque Pictet & Cie SA Takes Position in ResMed Inc. (NYSE:RMD) - MarketBeat
Kestra Private Wealth Services LLC Buys 4,702 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Here's Why ResMed (RMD) Could be Great Choice for a Bottom Fisher - MSN
ResMed Inc.'s (NYSE:RMD) Share Price Not Quite Adding Up - Simply Wall St
ResMed Updates Dividend Exchange Rate for CDI Holders - TipRanks
ResMed Inc. stock rises Thursday, outperforms market - MarketWatch
ResMed Inc. Reports Changes in CDI and Security Issuances - MSN
ResMed Close To Joining Very Elite Stock Group - MSN
Earnings call transcript: ResMed surpasses Q2 FY2025 earnings forecast, stock dips - MSN
State of Alaska Department of Revenue Decreases Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Shares Sold by Stephens Inc. AR - MarketBeat
ResMed Inc. (NYSE:RMD) Stake Lowered by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Mirae Asset Global Investments Co. Ltd. Buys 3,576 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Stephens Investment Management Group LLC Has $76.04 Million Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Holdings Lowered by Tobam - MarketBeat
Insider Sell: Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD) - GuruFocus.com
ResMed CFO Executes Planned Stock Transaction - TipRanks
ResMed CEO Executes Strategic Stock Transactions - TipRanks
ResMed Getting Closer To Key Technical Benchmark - MSN
Ex-Dividend Reminder: TJX Companies, UNITIL and ResMed - Nasdaq
Down 4%, is the ResMed share price in the buy zone? - MSN
Research Analysts Issue Forecasts for ResMed Q3 Earnings - MarketBeat
Resmed Chief Financial Officer Sells 1,000 Shares -February 10, 2025 at 06:33 pm EST - Marketscreener.com
Here's why I invested MORE money in ResMed shares last week - MSN
Resmed Inc Stock (RMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.83%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):